Emmaus Life Sciences EMMA
OTC EMMA
$0.06 +0.00 (+0.00%)
At close: Oct 21, 2026 · 4:00 PM EDT

Emmaus Life Sciences (EMMA) Income from Non-Controlling Interests (2018 - 2019)

Updated

Emmaus Life Sciences (EMMA) recorded Income from Non-Controlling Interests of $54,000 in Q3 2019.

Analysis

Emmaus Life Sciences (EMMA) Income from Non-Controlling Interests (2018 - 2019) Analysis & Trends

On a TTM basis, Emmaus Life Sciences' Income from Non-Controlling Interests came in at -$426,000 as of Sep 30, 2019; for FY2018, it was -$734,400.

  • Quarterly Income from Non-Controlling Interests has ranged from -$604,200 in Q2 2019 to $451,100 in Q1 2019 over the past five years.
  • Per Business Quant, the preceding three quarters came in at -$604,200 (Q2 2019), $451,100 (Q1 2019) and -$326,900 (Q4 2018).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn -
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn -
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 3.00 Mn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn -2.00 Mn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn -7.00 Mn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 1.00 Mn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 10.00 Mn
10 Emmaus Life Sciences 4.21 Mn -2.09 Mn 5.97 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2019 54,000.00
Jun 30, 2019 -604,200.00
Mar 31, 2019 451,100.00
Dec 31, 2018 326,900.00
Jun 30, 2018 -332,200.00
Mar 31, 2018 -72,300.00
API Access

Emmaus Life Sciences Income from Non-Controlling Interests API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=EMMA&period=max&api_key=YOUR_API_KEY